{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:17:57Z","timestamp":1788304677139,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"DOI":"10.1186\/s40644-026-01076-y","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T13:35:19Z","timestamp":1781962519000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative assessment of tumor burden in multiple myeloma using MY-RADS from whole-body MRI: comparison with established prognostic biomarkers"],"prefix":"10.1186","volume":"26","author":[{"given":"Xing","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyou","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"key":"1076_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"1076_CR2","doi-asserted-by":"crossref","unstructured":"Rajkumar SV. Treatment of multiple myeloma. Nat Rev Clin Onco. 2011;l 8:479\u201391.","DOI":"10.1038\/nrclinonc.2011.63"},{"issue":"12","key":"1076_CR3","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1076_CR4","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/leu.2009.61","volume":"23","author":"PN Hari","year":"2009","unstructured":"Hari PN, Zhang MJ, Roy V, et al. Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia. 2009;23(8):1528\u201334.","journal-title":"Leukemia"},{"issue":"6","key":"1076_CR5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0889-8588(05)70125-8","volume":"13","author":"J Blade","year":"1999","unstructured":"Blade J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am. 1999;13(6):1259\u201372.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1076_CR6","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.2147\/OTT.S122241","volume":"9","author":"MM Dupuis","year":"2016","unstructured":"Dupuis MM, Tuchman SA. Non-secretory multiple myeloma: from biology to clinical management. Onco Targets Ther. 2016;9:7583\u201390.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"1076_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/1042819031000151860","volume":"45","author":"A Anagnostopoulos","year":"2004","unstructured":"Anagnostopoulos A, Hamilos G, Zorzou MP, Grigoraki V, Anagnostou D, Dimopoulos MA. Discordant response or progression in patients with myeloma treated with thalidomide-based regimens. Leuk Lymphoma. 2004;45(1):113\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1076_CR8","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.3324\/haematol.2015.139816","volume":"101","author":"A Wale","year":"2016","unstructured":"Wale A, Pawlyn C, Kaiser M, Messiou C. Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma. Haematologica. 2016;101(4):e142\u20134.","journal-title":"Haematologica"},{"key":"1076_CR9","first-page":"1293","volume":"91","author":"BJ Bain","year":"2006","unstructured":"Bain BJ. Morbidity associated with bone marrow aspiration and trephine biopsy-a review of UK data for 2004. Haematologica. 2006;91:1293\u20134.","journal-title":"Haematologica"},{"key":"1076_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000358173","volume":"23","author":"I Berber","year":"2014","unstructured":"Berber I, Erkurt MA, Kuku I, et al. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula. Med Princ Pract. 2014;23:380\u20133.","journal-title":"Med Princ Pract"},{"issue":"4","key":"1076_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.hoc.2016.03.007","volume":"30","author":"B Amos","year":"2016","unstructured":"Amos B, Agarwal A, Kanekar S. Imaging of multiple myeloma. Hematol Oncol Clin North Am. 2016;30(4):843\u201365.","journal-title":"Hematol Oncol Clin North Am"},{"key":"1076_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1365-2141.2007.06491.x","volume":"137","author":"S D\u2019Sa","year":"2007","unstructured":"D\u2019Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M. Guidelines for the use of imaging in the management of myeloma. Br J Haematol. 2007;137:49\u201363.","journal-title":"Br J Haematol"},{"issue":"2","key":"1076_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejrad.2015.11.040","volume":"85","author":"JC Dutoit","year":"2016","unstructured":"Dutoit JC, Claus E, Offner F, Lucien Noens L, Delanghe J, Verstraete KL. Combined evaluation of conventional MRI, dynamic contrast-enhanced MRI and diffusion weighted imaging for response evaluation of patients with multiple myeloma. Eur J Radiol. 2016;85(2):373\u201382.","journal-title":"Eur J Radiol"},{"key":"1076_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood-2018-04-842880","volume":"132","author":"L Rasche","year":"2018","unstructured":"Rasche L, Angtuaco EJ, Alpe TL, et al. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood. 2018;132:59\u201366.","journal-title":"Blood"},{"key":"1076_CR15","doi-asserted-by":"publisher","first-page":"25254","DOI":"10.18632\/oncotarget.25402","volume":"9","author":"M Wennmann","year":"2018","unstructured":"Wennmann M, Kintzel\u00e9 L, Piraud M, et al. Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients. Oncotarget. 2018;9:25254\u201364.","journal-title":"Oncotarget"},{"key":"1076_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ajh.23258","volume":"87","author":"LA Moulopoulos","year":"2012","unstructured":"Moulopoulos LA, Dimopoulos MA, Kastritis E, et al. Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients. Am J Hematol. 2012;87:861\u20134.","journal-title":"Am J Hematol"},{"issue":"1","key":"1076_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1148\/radiol.2019181949","volume":"291","author":"C Messiou","year":"2019","unstructured":"Messiou C, Hillengass J, Delorme S, et al. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS). Radiology. 2019;291(1):5\u201313.","journal-title":"Radiology"},{"issue":"17","key":"1076_CR18","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1002\/cam4.4136","volume":"10","author":"A Belotti","year":"2021","unstructured":"Belotti A, Ribolla R, Cancelli V, et al. Predictive role of diffusion-weighted whole-body MRI (DW-MRI) imaging response according to MY-RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry. Cancer Med. 2021;10(17):5859\u201365.","journal-title":"Cancer Med"},{"issue":"2","key":"1076_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.21.26534","volume":"218","author":"H Dong","year":"2022","unstructured":"Dong H, Huang W, Ji X, et al. Prediction of Early Treatment Response in Multiple Myeloma Using MY-RADS Total Burden Score, ADC, and Fat Fraction From Whole-Body MRI: Impact of Anemia on Predictive Performance. AJR Am J Roentgenol. 2022;218(2):310\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"15","key":"1076_CR20","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005;23(15):3412\u201320.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1076_CR21","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar S, Paiva B, Anderson KC, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328\u201346.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1076_CR22","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.1525-139X.2009.00584.x","volume":"22","author":"TB Drueke","year":"2009","unstructured":"Drueke TB, Massy ZA. Beta2-microglobulin. Semin Dial. 2009;22(4):378\u201380.","journal-title":"Semin Dial"},{"issue":"3","key":"1076_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jmri.21072","volume":"26","author":"GP Liney","year":"2007","unstructured":"Liney GP, Bernard CP, Manton DJ, Turnbull LW, Langton CM. Age, gender, and skeletal variation in bone marrow composition: A preliminary study at 3.0 tesla. J Magn Reson Imaging. 2007;26(3):787\u201393.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1076_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2214\/AJR.11.8185","volume":"200","author":"AR Padhani","year":"2013","unstructured":"Padhani AR, van Ree K, Collins DJ, D\u2019Sa S, Makris A. Assessing the relation between bone marrow signal intensity and apparent diffusion coefficient in diffusion-weighted MRI. Am J Roentgenol. 2013;200(1):163\u201370.","journal-title":"Am J Roentgenol"},{"key":"1076_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1148\/radiol.2016160363","volume":"282","author":"V Koutoulidis","year":"2017","unstructured":"Koutoulidis V, Fontara S, Terpos E, et al. Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma. Radiology. 2017;282:484\u201393.","journal-title":"Radiology"},{"issue":"11","key":"1076_CR26","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1007\/s00330-014-3324-5","volume":"24","author":"JC Dutoit","year":"2014","unstructured":"Dutoit JC, Vanderkerken MA, Anthonissen J, Dochy F, Verstraete KL. The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma. Eur Radiol. 2014;24(11):2754\u201365.","journal-title":"Eur Radiol"},{"issue":"8","key":"1076_CR27","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.21037\/qims-20-1361","volume":"11","author":"M Sun","year":"2021","unstructured":"Sun M, Cheng J, Ren C, et al. Quantitative whole-body MR imaging for assessment of tumor burden in patients with multiple myeloma: correlation with prognostic biomarkers. Quant Imaging Med Surg. 2021;11(8):3767\u201380.","journal-title":"Quant Imaging Med Surg"},{"key":"1076_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1258\/ar.2010.100366","volume":"52","author":"J Hillengass","year":"2011","unstructured":"Hillengass J, Stieltjes B, B\u00e4uerle T, et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol. 2011;52:324\u201330.","journal-title":"Acta Radiol"},{"key":"1076_CR29","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00330-008-0943-8","volume":"18","author":"V Savvopoulou","year":"2008","unstructured":"Savvopoulou V, Maris TG, Vlahos L, Moulopoulos LA. Differences in perfusion parameters between upper and lower lumbar vertebral segments with dynamic contrast-enhanced MRI (DCE MRI). Eur Radiol. 2008;18:1876\u201383.","journal-title":"Eur Radiol"},{"key":"1076_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1148\/rg.301095066","volume":"30","author":"CJ Hanrahan","year":"2010","unstructured":"Hanrahan CJ, Christensen CR, Crim JR. Current Concepts in the Evaluation of Multiple Myeloma with MR Imaging and FDG PET\/CT. Radiographics. 2010;30:127\u201342.","journal-title":"Radiographics"},{"key":"1076_CR31","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.crad.2017.05.004","volume":"72","author":"C Lacognata","year":"2017","unstructured":"Lacognata C, Crim\u00ec F, Guolo A, et al. Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol. 2017;72:850\u20137.","journal-title":"Clin Radiol"},{"key":"1076_CR32","doi-asserted-by":"publisher","first-page":"e1198","DOI":"10.1259\/bjr\/52759767","volume":"85","author":"C Messiou","year":"2012","unstructured":"Messiou C, Giles S, Collins DJ, et al. Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol. 2012;85:e1198\u2013203.","journal-title":"Br J Radiol"},{"key":"1076_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00330-020-07412-5","volume":"31","author":"R Taghvaei","year":"2021","unstructured":"Taghvaei R, Zadeh MZ, Werner TJ, Alavi A. Critical role of PET\/CT-based novel quantitative techniques for assessing global disease activity in multiple myeloma and other hematological malignancies: why it is time to abandon reliance on examining focal lesions. Eur Radiol. 2021;31:149\u201351.","journal-title":"Eur Radiol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-026-01076-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-026-01076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:00:38Z","timestamp":1788303638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40644-026-01076-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1076"],"URL":"https:\/\/doi.org\/10.1186\/s40644-026-01076-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9563416\/v1","asserted-by":"object"}]},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the local institution and informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"116"}}